Literature DB >> 9593161

Assessment of the effects of combination therapy with ciprofloxacin and fenbufen on the central nervous systems of healthy volunteers by quantitative electroencephalography.

F Kamali1, C H Ashton, V R Marsh, J Cox.   

Abstract

The potential effects of concurrent administration of fenbufen and ciprofloxacin on central nervous system activity in healthy young subjects were investigated by electroencephalography (EEG). Visual analog scales (VAS) were used to assess subjective measures of concentration, vigilance, tension, and irritability. When ciprofloxacin was administered in combination with fenbufen, none of the EEG parameters or VAS ratings measured were significantly different from those measured when the drugs were administered alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593161      PMCID: PMC105795          DOI: 10.1128/AAC.42.5.1256

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Effect of the anti-inflammatory agent fenbufen on the quinolone-induced inhibition of gamma-aminobutyric acid binding to rat brain membranes in vitro.

Authors:  A Tsuji; H Sato; E Okezaki; O Nagata; H Kato
Journal:  Biochem Pharmacol       Date:  1988-11-15       Impact factor: 5.858

Review 2.  The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

3.  The effect of caffeine, nitrazepam and cigarette smoking on the contingent negative variation in man.

Authors:  H Ashton; J E Millman; R Telford; J W Thompson
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1974-07

4.  Contingent negative variation and the distraction--arousal hypothesis.

Authors:  J J Tecce; J Savignano-Bowman; D Meinbresse
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1976-09

5.  Possible interaction of fluoroquinolones with the benzodiazepine-GABAA-receptor complex.

Authors:  E Unseld; G Ziegler; A Gemeinhardt; U Janssen; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

6.  Ciprofloxacin: an update on clinical experience.

Authors:  G Arcieri; E Griffith; G Gruenwaldt; A Heyd; B O'Brien; N Becker; R August
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

Review 7.  Ciprofloxacin: an overview of adverse experiences.

Authors:  P Ball
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

8.  Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.

Authors:  S Segev; M Rehavi; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

9.  Lack of a pharmacokinetic interaction between ciprofloxacin and fenbufen.

Authors:  F Kamali
Journal:  J Clin Pharm Ther       Date:  1994-08       Impact factor: 2.512

10.  Pharmacokinetic and pharmacodynamic responses to caffeine in poor and normal sleepers.

Authors:  P Tiffin; H Ashton; R Marsh; F Kamali
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.